The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world's leading Source plasma collectors and producers of plasma-based and recombinant biological therapies. The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficiency, burns and shock. As the global representative for the plasma collection and therapeutics industry. PPTA works cooperatively with patient groups, policymakers, regulatory agencies and other stakeholders to address critical issues.

PPTA is pleased to announce the first International Plasma Awareness Week (IPAW) to be celebrated October 13-20, 2013. The Association and its member companies are planning activities and events designed to:

--Raise awareness about source plasma collection
--Celebrate and recognize the contributions of plasma donors
--Expand knowledge about plasma protein therapies and rare diseases 

 Additional information will be forthcoming.